SSY Group Limited announced that the Group has obtained the approval for drug production and registration for Metronidazole and Sodium Chloride Injection in form of polypropylene infusion bottle packaging (two specifications including 250ml:1.25g and 100ml:0.5g) from the National Medical Products Administration of China. This packaging of plastic bottle is an addition to the multi-layer co- extrusion film infusion bag which has passed the consistency evaluation. Metronidazole is a commonly used antibiotic, which is mainly used in treatment or prevention of systemic or local infections caused by anaerobic bacteria, and in treatment of anaerobic bacterial infections in abdominal cavity, digestive tract, female reproductive system and oral cavity.

In addition, the Board is also pleased to announce that the Group has obtained the approval from the National Medical Products Administration of China for using the Group's own bulk drug Rosuvastatin calcium in its production of corresponding preparations product Rosuvastatin Calcium Tablets. Rosuvastatin calcium is mainly used in treatment of primary hypercholesterolemia or mixed dyslipidemia.